We are live on ! Find out more
MIG

McGuire Investment Group Portfolio holdings

AUM $1.14B
1-Year Est. Return 79.59%
This Fund
S&P 500
This Quarter Est. Return
+9.12%
1 Year Est. Return
+79.59%
3 Year Est. Return
+184.19%
5 Year Est. Return
+218.18%
10 Year Est. Return
AUM
$462M
AUM Growth
+$23.1M
Cap. Flow
-$9.22M
Cap. Flow %
-2%
Top 10 Hldgs %
34.96%
Holding
121
New
8
Increased
57
Reduced
31
Closed
6

Sector Composition

Rank Sector Weight
1 Technology 28.18%
2 Healthcare 26.18%
3 Financials 11.07%
4 Industrials 6.37%
5 Consumer Staples 2.87%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AMD icon
1
Advanced Micro Devices
AMD
$799B
$18.5M 4.01%
285,782
+1,831
+0.6% +$121K
TMO icon
2
Thermo Fisher Scientific
TMO
$214B
$17.9M 3.87%
32,506
+6
+0% +$3.18K
QCOM icon
3
Qualcomm
QCOM
$168B
$17.8M 3.86%
162,152
+693
+0.4% +$81.1K
LRCX icon
4
Lam Research
LRCX
$383B
$15.9M 3.44%
377,660
+3,080
+0.8% +$129K
AMAT icon
5
Applied Materials
AMAT
$419B
$15.6M 3.37%
159,870
+1,355
+0.9% +$130K
AAPL icon
6
Apple
AAPL
$4.56T
$15.5M 3.35%
119,269
+204
+0.2% +$29.2K
ADI icon
7
Analog Devices
ADI
$184B
$15.4M 3.33%
93,764
+396
+0.4% +$61.8K
IQV icon
8
IQVIA
IQV
$38.3B
$15.2M 3.3%
74,410
-15,052
-17% -$3.05M
XBI icon
9
State Street SPDR S&P Biotech ETF
XBI
$10.1B
$14.9M 3.24%
180,102
-9,276
-5% -$751K
BIL icon
10
State Street SPDR Bloomberg 1-3 Month T-Bill ETF
BIL
$46.9B
$14.8M 3.2%
161,517
+67,142
+71% +$6.14M
SYK icon
11
Stryker
SYK
$129B
$14.3M 3.1%
58,592
+73
+0.1% +$16.6K
CBOE icon
12
Cboe Global Markets
CBOE
$30.2B
$12.5M 2.71%
99,701
+668
+0.7% +$82.4K
MSFT icon
13
Microsoft
MSFT
$3.71T
$12.1M 2.63%
50,651
+417
+0.8% +$100K
SCHW
14
Charles Schwab
SCHW
$187B
$11.5M 2.49%
137,959
+1,032
+0.8% +$80.1K
HOLX
15
DELISTED
Hologic
HOLX
$10.8M 2.34%
144,310
+616
+0.4% +$43.9K
USFR icon
16
WisdomTree Floating Rate Treasury Fund
USFR
$18.4B
$10.4M 2.25%
207,235
+14,822
+8% +$746K
JNJ icon
17
Johnson & Johnson
JNJ
$619B
$10.3M 2.24%
58,560
+240
+0.4% +$41.4K
MEDP icon
18
Medpace
MEDP
$16.3B
$10M 2.17%
47,228
-15,180
-24% -$3.03M
ITW icon
19
Illinois Tool Works
ITW
$84.8B
$9.84M 2.13%
44,661
+269
+0.6% +$57.3K
DHR icon
20
Danaher
DHR
$141B
$9.73M 2.11%
41,355
+463
+1% +$107K
IBB icon
21
iShares Biotechnology ETF
IBB
$9.53B
$8.77M 1.9%
66,815
+5,836
+10% +$754K
COST icon
22
Costco
COST
$421B
$8.71M 1.89%
19,080
+108
+0.6% +$52.8K
BMY icon
23
Bristol-Myers Squibb
BMY
$131B
$8.52M 1.84%
118,456
-362
-0.3% -$27.3K
ASML icon
24
ASML
ASML
$655B
$7.89M 1.71%
14,434
+3,363
+30% +$1.76M
NVDA icon
25
NVIDIA
NVDA
$5.3T
$7.62M 1.65%
521,150
+4,560
+0.9% +$66.9K

Similar funds

McGuire Investment Group's Q4 2022 Portfolio in Review

As of Q4 2022, McGuire Investment Group held 121 positions worth $462M, up 5.3% from $439M the previous quarter. Its ten largest holdings account for 35% of the portfolio.

McGuire Investment Group's Q4 2022 filing shows 8 new, 57 increased, 31 reduced and 6 closed positions. Its largest new stake was Intellia Therapeutics: 35,081 shares worth $1.22M. The largest sale was State Street SPDR Bloomberg Investment Grade Floating Rate ETF, an estimated $6.58M.

By sector, the portfolio is most concentrated in Technology at 28% of assets, up from 28% a quarter earlier, followed by Healthcare and Financials.

  • McGuire Investment Group's largest Q4 2022 buy was Intellia Therapeutics: 35,081 shares worth $1.22M.
  • McGuire Investment Group added most to State Street SPDR Bloomberg 1-3 Month T-Bill ETF in Q4 2022, an estimated $6.14M increase.
  • McGuire Investment Group's biggest Q4 2022 reduction was State Street SPDR Bloomberg Investment Grade Floating Rate ETF, cutting an estimated $6.58M.
  • McGuire Investment Group fully exited Western Digital in Q4 2022, selling an estimated $1.6M.
  • McGuire Investment Group's ten largest holdings make up 35% of its $462M portfolio in Q4 2022.
  • McGuire Investment Group opened 8 new positions and closed 6 in Q4 2022.
  • McGuire Investment Group's portfolio value rose 5.3% quarter-over-quarter to $462M.

Based on McGuire Investment Group's 13F filing for Q4 2022, filed 10 Jan 2023.